Connaughton Bernadette — SEC insider filings

SEC reporting owner CIK 1662521. 27 insider filings on record with FilingPulse; latest filed 2026-10-08.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2021-05-06 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
HALOZYME THERAPEUTICS, INC. (HALO)Director17—13 legs · 17,330 sh · $1,284,58312
Editas Medicine, Inc. (EDIT)Director6——6
Syneos Health, Inc. (SYNH)Director4——5

Insider filings — Connaughton Bernadette

FiledFormIssuerReported transactionsSource
2026-10-084/AHALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 3,796 @ $0EDGAR
2026-08-114HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 1,626 @ $102.80EDGAR
2026-07-024HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 1,000 @ $76.39 · Sale (S): 625 @ $77.21EDGAR
2026-06-224Editas Medicine, Inc. (EDIT)Grant/award (A): 51,700 (derivative) @ $0EDGAR
2026-06-024HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 1,625 @ $66.21EDGAR
2026-05-074HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 6,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0EDGAR
2026-05-054HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 1,625 @ $63.48EDGAR
2026-01-064HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 2,000 @ $70.25EDGAR
2025-12-014HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 829 @ $71.60EDGAR
2025-11-124HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 2,000 @ $68.48EDGAR
2025-10-014HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 1,500 @ $75.09 · Sale (S): 500 @ $75.70EDGAR
2025-09-024HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 100 @ $71.71 · Sale (S): 2,977 @ $73.62 · Sale (S): 923 @ $74.11EDGAR
2025-06-104Editas Medicine, Inc. (EDIT)Grant/award (A): 37,500 (derivative) @ $0EDGAR
2025-05-024HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 4,165 @ $0 · Grant/award (A): 5,750 (derivative) @ $0EDGAR
2024-06-034Editas Medicine, Inc. (EDIT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-04-294HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 6,501 @ $0 · Grant/award (A): 8,804 (derivative) @ $0EDGAR
2023-09-284Syneos Health, Inc. (SYNH)Disposition to issuer (D): 9,915 @ $43 · Disposition to issuer (D): 4,863 @ $0EDGAR
2023-06-054Editas Medicine, Inc. (EDIT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-05-304Syneos Health, Inc. (SYNH)Grant/award (A): 4,863 @ $0EDGAR
2023-05-094HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 8,065 @ $0 · Grant/award (A): 11,371 (derivative) @ $0EDGAR
2022-11-174HALOZYME THERAPEUTICS, INC. (HALO)Gift (G): 5,998 @ $0EDGAR
2022-06-134Editas Medicine, Inc. (EDIT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-05-274Syneos Health, Inc. (SYNH)Grant/award (A): 2,839 @ $0EDGAR
2022-05-064HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 6,206 @ $0EDGAR
2021-10-284Editas Medicine, Inc. (EDIT)Grant/award (A): 24,732 (derivative) @ $0EDGAR
2021-05-144Syneos Health, Inc. (SYNH)Grant/award (A): 2,364 @ $0EDGAR
2021-05-064HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 5,230 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662521 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs